Natural unblinding of BCG vaccination trials

There is significant public and clinical interest in the potential for Bacillus Calmette-Guérin (BCG) vaccination to protect against type 2 Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-2) induced COVID-19. This question could be best answered by blinded and placebo controlled clinical tri...

Descripción completa

Detalles Bibliográficos
Autores principales: Szigeti, Reka, Kellermayer, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7969911/
https://www.ncbi.nlm.nih.gov/pubmed/33744042
http://dx.doi.org/10.1016/j.vaccine.2021.03.039

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7969911/
https://www.ncbi.nlm.nih.gov/pubmed/33744042
http://dx.doi.org/10.1016/j.vaccine.2021.03.039

Ejemplares similares